Cancer Vaccine Market 2025 to 2034
Cancer Vaccine Market 2025 to 2034
Cancer Vaccine Market (By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines, Others; By Indication: Cervical Cancer, Prostate Cancer, Other Indications; By Technology: Recombinant Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, Whole-cell Cancer Vaccines, Others; By Distribution Channel: Hospitals, Government Suppliers; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 12.61 Bn
Forecast Year, 2034
USD 33.38 Bn
CAGR, 2025 - 2034
11.42%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global cancer vaccine market, valued at USD 12.61 billion in 2025, is projected to reach USD 33.38 billion by 2034, growing at a robust CAGR of 11.42%. Increasing prevalence of cancer and advancements in immunotherapy are driving market expansion.
Cancer Vaccine Market Size Analysis
Cancer Vaccine Market Size By Type 2025 to 2034 (USD Billion)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Preventive Cancer Vaccines | 4.35 | 4.84 | 5.40 | 6.01 | 6.70 | 7.46 | 8.32 | 9.27 | 10.33 | 11.50 |
| Therapeutic Cancer Vaccines | 6.97 | 7.77 | 8.65 | 9.64 | 10.74 | 11.97 | 13.34 | 14.86 | 16.56 | 18.45 |
| Others | 1.29 | 1.44 | 1.60 | 1.79 | 1.99 | 2.22 | 2.47 | 2.76 | 3.07 | 3.42 |
Cancer Vaccine Market Size By Indication 2025 to 2034 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cervical Cancer | 5.20 | 5.80 | 6.46 | 7.20 | 8.02 | 8.93 | 9.95 | 11.09 | 12.36 | 13.77 |
| Prostate Cancer | 3.54 | 3.94 | 4.39 | 4.90 | 5.45 | 6.08 | 6.77 | 7.54 | 8.41 | 9.37 |
| Other Indications | 3.87 | 4.31 | 4.80 | 5.35 | 5.96 | 6.64 | 7.40 | 8.25 | 9.19 | 10.24 |
Cancer Vaccine Market Size By Technology 2025 to 2034 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant Cancer Vaccines | 4.22 | 4.70 | 5.23 | 5.83 | 6.50 | 7.24 | 8.07 | 8.99 | 10.01 | 11.16 |
| Viral Vector and DNA Cancer Vaccines | 3.27 | 3.64 | 4.06 | 4.52 | 5.04 | 5.61 | 6.25 | 6.97 | 7.76 | 8.65 |
| Whole-cell Cancer Vaccines | 2.80 | 3.12 | 3.48 | 3.88 | 4.32 | 4.81 | 5.36 | 5.97 | 6.66 | 7.42 |
| Others | 2.32 | 2.59 | 2.88 | 3.21 | 3.58 | 3.99 | 4.45 | 4.95 | 5.52 | 6.15 |
Cancer Vaccine Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 8.98 | 10.00 | 11.14 | 12.42 | 13.83 | 15.41 | 17.17 | 19.14 | 21.32 | 23.76 |
| Government Suppliers | 3.63 | 4.05 | 4.51 | 5.03 | 5.60 | 6.24 | 6.95 | 7.75 | 8.63 | 9.62 |
Cancer Vaccine Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 4.73 | 5.27 | 5.87 | 6.55 | 7.29 | 8.13 | 9.05 | 10.09 | 11.24 | 12.52 |
| Europe | 3.02 | 3.36 | 3.75 | 4.18 | 4.65 | 5.18 | 5.78 | 6.44 | 7.17 | 7.99 |
| Asia Pacific | 2.80 | 3.11 | 3.47 | 3.87 | 4.31 | 4.80 | 5.35 | 5.96 | 6.64 | 7.40 |
| Latin America | 1.16 | 1.29 | 1.43 | 1.60 | 1.78 | 1.98 | 2.21 | 2.46 | 2.74 | 3.06 |
| Middle East and Africa | 0.91 | 1.01 | 1.13 | 1.26 | 1.40 | 1.56 | 1.74 | 1.93 | 2.16 | 2.40 |
Cancer Vaccine Market Size to Lead USD 33.38 Billion by 2034
The global cancer vaccine market size was evaluated at USD 12.61 billion in 2025 and is expected to grow around USD 33.38 billion by 2034 a CAGR of 11.42%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
